孕期使用SSRI/SNRI与先天性心脏病产前诊断的流行病学关联
多变量分析显示,孕早期使用SSRI/SNRI、有焦虑或情绪障碍史但未用药、孕妇年龄>40岁与CHD独立相关,而孕早期使用叶酸和/或孕期复合维生素则与风险降低相关。
要点
- 孕早期使用SSRI/SNRI与CHD风险升高独立相关(RR 4.14)。
- 有焦虑或情绪障碍史但孕早期未用SSRI/SNRI者CHD风险亦升高(RR 2.20)。
- 孕早期使用叶酸和/或复合维生素与CHD风险降低相关(RR 0.69)。
核心结论
- 母亲情绪障碍无论是否使用SSRI/SNRI、孕妇年龄>40岁及缺乏复合维生素/叶酸使用均与妊娠期CHD独立相关。
主要发现
- 多变量分析显示CHD与孕早期使用SSRI/SNRI独立相关(RR 4.14,95%CI 2.58-6.65)。
- 有焦虑或情绪障碍史但孕早期未使用SSRI/SNRI与CHD独立相关(RR 2.20,95%CI 1.77-2.74)。
- 孕早期使用叶酸和/或孕期复合维生素与CHD风险降低独立相关(RR 0.69,95%CI 0.55-0.87)。
- 孕妇年龄>40岁与CHD风险升高独立相关(RR 2.30,95%CI 1.57-3.38)。
临床怎么用
- 对孕早期使用SSRI/SNRI或有情绪障碍史的孕妇应关注CHD风险并考虑产前筛查。
- 孕早期补充叶酸和/或孕期复合维生素可能降低CHD风险。
- 孕妇年龄>40岁应纳入CHD风险咨询与产前诊断评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Identify early pregnancy associations of congenital heart disease (CHD) in a multiethnic cohort. METHODS: This retrospective observational cohort study compared the general obstetric population to women who gave birth at a referral centre in Australia between 2012 and 2017, after 20 weeks' of gestation, with a pregnancy affected by CHD. We defined mood disorder and anxiety as a history of self-reported or medically diagnosed anxiety, depression, postpartum depression or bipolar disorder. RESULTS: We compared epidemiological factors between 30 842 general obstetric patients and 470 obstetric patients with a foetus affected by CHD. Multivariate analysis showed independent associations between CHD and use of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) in the first trimester (relative risk [RR] 4.14, 95% CI 2.58-6.65), history of anxiety or mood disorder with no SSRI/SNRI first trimester (RR 2.20, 95% CI 1.77-2.74), folate and/or pregnancy multivitamin use in the first trimester (RR 0.69, 95% CI 0.55-0.87) and increased risk with maternal age >40 years (RR 2.30, 95% CI 1.57-3.38). CONCLUSIONS: Our data show maternal mood disorders with and without SSRI or SNRI use, maternal age >40 years and lack of multivitamin/folate use to be independently associated with CHD in pregnancy.
引用
- Melov SJ, Shetty PS, Pasupathy D, et al. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease. Prenat Diagn. 2020. PMID: 33067884. doi:10.1002/pd.5846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。